Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
65,000,000
-
Number of holders
-
217
-
Total 13F shares, excl. options
-
49,572,751
-
Shares change
-
+2,942,254
-
Total reported value, excl. options
-
$4,675,884,768
-
Value change
-
+$324,726,215
-
Put/Call ratio
-
59%
-
Number of buys
-
145
-
Number of sells
-
76
-
Price
-
$94.33
Institutional Holders of Blueprint Medicines Corp - Common Stock, par value $0.001 per share (BPMC) as of Q2 2019
As of 30 Jun 2019 Blueprint Medicines Corp - Common Stock, par value $0.001 per share (BPMC) had 217 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 49,572,751 shares of stock of the company.
Largest 10 holders included FMR LLC, VANGUARD GROUP INC, BlackRock Inc., PRICE T ROWE ASSOCIATES INC /MD/, WELLINGTON MANAGEMENT GROUP LLP, Invesco Ltd., STATE STREET CORP, HILLHOUSE CAPITAL ADVISORS, LTD., PERCEPTIVE ADVISORS LLC, and ALLIANCEBERNSTEIN L.P..
This table shows 217 institutional shareholders of the security as of 30 Jun 2019.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.